Mount Sinai's Knowledge Management Center for Illuminating the Druggable Genome
Mount Sinai's Knowledge Management Center for Illuminating the Druggable Genome
批准号:
8785466
负责人:
Joel Thomas Dudley
金额:
$62.13万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-08-01 至 2016-07-31
关键词:
Adverse effectsAttenuatedCollaborationsDataDiseaseFamilyFibrosisFoundationsGene TargetingGenomeIndividualInformation Resources ManagementInvestigationIon ChannelKidneyLinkLiteratureMolecular and Cellular BiologyNuclear ReceptorsPatientsPharmaceutical PreparationsPositioning AttributeProductivityProtein KinaseResearchSourceSource CodeTertiary Protein StructureValidationabstractingbasedisease phenotypeinnovation
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: The Knowledge Management Center for Illuminating the Druggable Genome (KMC-IDG) at Mount Sinai will assemble, organize and visualize data collected from the under-studied druggable genome from the four families: protein kinases, nuclear receptor, ion channels and GPCRs. The KMC-IDG will also attempt linking such under-studied druggable targets for their potential applications in various diseases. To achieve this we will assemble and abstract data from four domains: proteins/genes/targets, drugs/perturbagens, diseases/phenotypes/side-effects, and data from individual patients. Various pipe-lines and workflow will be established to connect clusters of patients from various diseases to under-studied druggable targets. The Ma'ayan and Dudley Labs are well positioned to carry out successfully this project based on their prior track record of productivity, foundation of source code and data that is already collected and organized, and strong existing user base that can be directed to the newly developed portal. In addition, both labs have a strong track record of collaborations including the computational identification and experimental validation of at least one under-studied protein kinase as a potential important target for attenuating kidney fibrosis. One unique and innovative research component of this project is an investigation into the sources of the literature and experimental biases that exist in the molecular and cellular biology research domains.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Integrated understanding of complex viral network biology in Alzheimer's Disease
-
批准号:9557996
-
项目类别:
-
资助金额:$84.41万
-
财政年份:2017
-
负责人:Joel Thomas Dudley
-
依托单位:
Pre-clinical Testing of a Novel Therapeutic for Nonalcoholic Steatohepatitis
-
批准号:9386379
-
项目类别:
-
资助金额:$33.85万
-
财政年份:2017
-
负责人:Joel Thomas Dudley
-
依托单位:
Data Organization Core
-
批准号:8934410
-
项目类别:
-
资助金额:$44.92万
-
财政年份:2014
-
负责人:Joel Thomas Dudley
-
依托单位:
Mount Sinai's Knowledge Management Center for Illuminating the Druggable Genome
-
批准号:9558160
-
项目类别:
-
资助金额:$6.6万
-
财政年份:2014
-
负责人:Joel Thomas Dudley
-
依托单位:
Network Based Predictive Drug Discovery for Alzheimer's Disease
-
批准号:8849718
-
项目类别:
-
资助金额:$36.65万
-
财政年份:2014
-
负责人:Joel Thomas Dudley
-
依托单位:
Mount Sinai's Knowledge Management Center for Illuminating the Druggable Genome
-
批准号:9325632
-
项目类别:
-
资助金额:$56.2万
-
财政年份:2014
-
负责人:Joel Thomas Dudley
-
依托单位:
Administrative Core
-
批准号:8934412
-
项目类别:
-
资助金额:$10.01万
-
财政年份:2014
-
负责人:Joel Thomas Dudley
-
依托单位:
User Interface Portal
-
批准号:8934411
-
项目类别:
-
资助金额:$7.21万
-
财政年份:2014
-
负责人:Joel Thomas Dudley
-
依托单位:
Methods for Evolutionary Informed Network Analysis to Discover Disease Variation
-
批准号:8826738
-
项目类别:
-
资助金额:$41.46万
-
财政年份:2013
-
负责人:Joel Thomas Dudley
-
依托单位:
Methods for Evolutionary Informed Network Analysis to Discover Disease Variation
-
批准号:8482670
-
项目类别:
-
资助金额:$43.15万
-
财政年份:2013
-
负责人:Joel Thomas Dudley
-
依托单位:
Methods for Evolutionary Informed Network Analysis to Discover Disease Variation
-
批准号:8627167
-
项目类别:
-
资助金额:$41.44万
-
财政年份:2013
-
负责人:Joel Thomas Dudley
-
依托单位:
Methods for Evolutionary Informed Network Analysis to Discover Disease Variation
-
批准号:9041579
-
项目类别:
-
资助金额:$41.46万
-
财政年份:2013
-
负责人:Joel Thomas Dudley
-
依托单位:
Administrative Core
-
批准号:8934415
-
项目类别:
-
资助金额:$9.24万
-
财政年份:--
-
负责人:Joel Thomas Dudley
-
依托单位:
海外基金